iSelect Fund
  • Portfolio
  • Team
  • Focus Areas
    • Food & Agriculture
    • Healthcare
    • Food is Health
    • Soil Health
    • Impact Investing
    • Entrepreneurs
  • Invest
  • Insights
  • Contact
  • My iSelect
    • My iSelect Login
Select Page

Molecular Assemblies to Provide Enzymatic Synthesis Technology to DARPA NOW Project for On-Demand DNA/RNA Vaccine Manufacturing

Read more

Molecular Assemblies Appoints Phil Paik, Ph.D., Vice President, Platform Development

Read more

A New Way Of Making DNA Is About To Revolutionize The Biotech Industry

Read more

A New Way Of Making DNA Is About To Revolutionize The Biotech Industry

Read more

Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis

Read more

Mike Kamdar, The Future Of DNA Writing, And The Business Of Biology

Read more
« Older Entries

Related Posts

  • Tools for Temporary Staffing
    Better Weekdays: The Future of Hiring Is Here
  • Invest in Innovation
    The Midwest Isn’t the New Silicon Valley - It’s Our Fault
  • RNA
    RNA Is Becoming the New DNA, Opening New Doors in Medicine
  • Startup
    10 Common Mistakes Made When Investing in Startups
  • How Aquaculture Factors into the Future of Food
AgTechFund BLOG SIDEBAR

(314) 219-8688

7750 Maryland Ave
Box 11826
St. Louis, MO 63105

Crunchbase   Twitter   LinkedIn   Facebook   YouTube

Securities offered through North Capital Private Securities ("NCPS"), Member FINRA/SIPC, located at 623 East Ft. Union Blvd, Suite 101, Salt Lake City, UT 84047. NCPS does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform.  Please review North Capital’s Form CRS and its background on FINRA’s BrokerCheck.  Investments in private offerings are speculative, illiquid and involve a high degree of risk and those investors who cannot afford to lose their entire investment and who cannot hold an investment for an indeterminate period should not invest in such offerings. Past performance is not indicative of future results.  All information provided herein should not be relied upon to make an investment decision and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Prospective investors are recommended to consult with a financial adviser, attorney, accountant, and any other professional that can help you understand and assess the risks associated with an investment opportunity. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.